The biopsy is a gold standard method for tumor grading. However, due to its invasive nature, it has sometimes proved fatal for brain tumor patients. As a result, a non-invasive computer-aided diagnosis (CAD) tool is required.
View Article and Find Full Text PDFBackground: Although biopsy is the gold standard for tumour grading, being invasive, this procedure also proves fatal to the brain. Thus, non-invasive methods for brain tumour grading are urgently needed. Here, a magnetic resonance imaging (MRI)-based non-invasive brain tumour grading method has been proposed using deep learning (DL) and machine learning (ML) techniques.
View Article and Find Full Text PDFCOVID-19 has infected 77.4 million people worldwide and has caused 1.7 million fatalities as of December 21, 2020.
View Article and Find Full Text PDFMotivation: Brain or central nervous system cancer is the tenth leading cause of death in men and women. Even though brain tumour is not considered as the primary cause of mortality worldwide, 40% of other types of cancer (such as lung or breast cancers) are transformed into brain tumours due to metastasis. Although the biopsy is considered as the gold standard for cancer diagnosis, it poses several challenges such as low sensitivity/specificity, risk during the biopsy procedure, and relatively long waiting times for the biopsy results.
View Article and Find Full Text PDFA World Health Organization (WHO) Feb 2018 report has recently shown that mortality rate due to brain or central nervous system (CNS) cancer is the highest in the Asian continent. It is of critical importance that cancer be detected earlier so that many of these lives can be saved. Cancer grading is an important aspect for targeted therapy.
View Article and Find Full Text PDF